CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
...ich BioGlue((R)) Surgical Adhesive was developed. bioglue is approved by the U.S. Food and Drug Administrati...staples in open surgical repair of large vessels. bioglue is also CE marked in the European Community and ap...atients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and ap...CryoLife Reports Record Quarterly Revenues of $28.2 Million
...t during the second quarter of 2008, which reduced bioglue revenues by $331,000 for the second quarter of 2009, bioglue revenues would have been $12.7 million. bioglue revenues were $24.1 million for the first six mont...BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates
... market in 1998 and in the United States in 2001. bioglue is a leading surgical adhesive used in cardiovascular surgeries worldwide. "I have been using bioglue since its market introduction almost 10 years ago,...ist Hospital, Indianapolis, Ind. "I have utilized bioglue in over 1,000 patients undergoing a variety of car...Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology
...n adjunct to sutures and staples in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Aust...taples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Aust...William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education
... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoL...CryoLife Reports Record First Quarter Revenues of $26.7 Million
...ere was a 2 percent increase in the milliliters of bioglue shipped, revenues decreased 1 percent. Excluding ...exchange rates quarter over quarter, which reduced bioglue revenues by $306,000 in the first quarter of 2009, bioglue revenues would have been $12.1 million, or a 2 per...CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum
...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
...fourth quarter of 2007, an increase of 5 percent. bioglue revenues were $48.6 million for the year ended Dec...r 31, 2007, an increase of 11 percent. U.S. bioglue revenues were $8.6 million and $8.1 million for th...rth quarters of 2008 and 2007, respectively. U.S. bioglue revenues were $34.4 million and $31.6 million for ...CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc.
... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...